Cognitive Rehabilitation, Fibromyalgia
Conditions
Brief summary
In recent years, especially in developed countries, FMS has emerged as a serious social problem by decreasing labour force and quality of life. Especially clinicians have started to consider cognitive dysfunction in FMS as a separate clinical condition. In the light of the data obtained, can say that cognitive dysfunction increases in the presence of depression, anxiety, sleep disorders, endocrine imbalances and pain. Neuroscience and technological advances make it possible to meet the demand for care and improve the quality of stimulation by enabling the automation of many cognitive training procedures, improving patient record reliability and optimising performance of disability functions. The recently implemented RehaCom and HeadApp programmes (Schuhfried, Austria). excellent results have been reported in clinical practice with no significant adverse effects. This study will investigate the effectiveness of a cognitive rehabilitation programme using computer software in female patients with fibromyalgia.
Interventions
DEVICEcognitive rehabilitation with computer software
3-5 sessions per week, 4 weeks cognitive rehabilitation with computer software
Sponsors
Savaş Karpuz
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Being a woman * Diagnosed with fibromyalgia * 18-65 years old
Exclusion criteria
* concomitant neurological disorder, learning disorder or cognitive impairment * current alcohol or recreational drug dependence or long-term (≥5 years) history of substance abuse * visual or hearing impairment that would interfere with cognitive testing * diagnosis of untreated obstructive sleep apnoea, * atypical sleep/wake patterns (e.g. night shift workers) * Lack of computer and internet access
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stroop Colour and Word Test | start and first month |
| Number Range Test | start and first month |
Secondary
| Measure | Time frame |
|---|---|
| modified Fibromyalgia impact questionnaire | start and first month |
Outcome results
None listed